"After the spin-off, iFLYTEK will still maintain control of iFLYTEK Medical. "This article is the original of IPO.
Author Uncle C.
According to the IPO early news, on January 9, iFLYTEK (002230SZ) announced its plan to spin off its holding subsidiary, iFLYTEK Medical Technology Co., Ltd., to be listed on the main board of the Hong Kong Stock Exchange.
The initial offering size of iFLYTEK Medical in this offering is no more than 15 of the enlarged total share capital immediately after the issuance (before the exercise of the over-allotment right), that is, no more than 2,008990,000 shares, and grant the global coordinator The bookrunner has an over-allotment option of no more than 15% of the initial issue size of the above-mentioned H shares, that is, in the case of full exercise of the over-allotment right, the number of H shares issued by iFLYTEK Medical this time is intended to not exceed 2,310340,000 shares. After the spin-off, iFLYTEK will still maintain control of iFLYTEK Medical.
Founded in 2016, with the goal of creating "AI diagnosis and treatment assistant for every doctor and AI health assistant for everyone", iFLYTEK Medical has built an artificial intelligence medical solution system based on core technologies such as medical semantic computing, text understanding, knowledge reasoning, and data mining, aiming at the wide range of medical industry practitioners such as primary medical institutions, hospitals, patients and residents, and realizing the coverage of the whole medical process from disease early warning, early screening, diagnosis, ** and efficacy evaluation, post-diagnosis and chronic disease management. Relying on proprietary algorithm modules and machine learning models, iFLYTEK has technical advantages in medical knowledge Q&A, complex medical language understanding, professional medical document generation, diagnosis recommendation, multi-round interaction and multi-modal interaction.
In 2017, iFLYTEK Medical undertook the construction of Anhui Provincial Hospital, the First Affiliated Hospital of the University of Science and Technology of China, the first smart hospital in China, and the general practice auxiliary diagnosis and treatment system (intelligent medical assistant) developed by iFLYTEK Medical passed the qualification examination for clinical practitioners. In 2020, the intelligent medical assistant completed the full coverage of 104 districts and counties in Anhui Province, and the public health robot service exceeded 300 million people.
In October 2023, iFLYTEK released the iFLYTEK Xinghuo cognitive model v30 surpasses ChatGPT as a whole, and the iFLYTEK Xinghuo medical model surpasses GPT-4 in 6 core capabilities such as medical massive knowledge Q&A, medical complex language understanding, and medical professional document generation. The iFLYTEK Xinghuo medical model will create an AI health assistant for everyone.
According to the announcement, from 2020 to 2022, iFLYTEK Medical's revenue will be 32.1 billion yuan, 3$5.6 billion and $49.4 billion yuan, and the net profit attributable to the parent company was 76.1 billion390,000 yuan, -7973$230,000 and -20.4 billion yuan.